What are the breast cancer biomarkers?
- BRCA1
- BRCA2
- ATM
- CDH1
- CHEK2
- NBN
- NF1
- PALB2
- PTEN
- STK11
- TP53 (p53)
- Rb
- HER2
- FGFR1/FGFR2/FGFR3
- PIK3CA
- PD-L-1
What is the purpose of genetic testing for breast cancer biomakers?
Gaining information on your breast cancer tumor characteristics at the genetic level may give information that is useful for making treatment decisions; those are sometimes called “biomarkers.” Some clinical trials require the presence or absence of a certain biomarker / genetic alteration. Those trials may require this information in advance of application to the trial, while others may ask for a biopsy of your tumor, and perform the testing on site.
Ready to Own Your Breast Cancer Journey?
- Complete the breast cancer questionnaire.
- Get your list of advanced breast cancer treatment options.
- Compare treatments of patients like you.
- Learn about the treatment or trial that’s right for you.
- Get the guidance you need.
BREAST CANCER COMMUNITY
Clinical Trial Experience Interview: Hedva Gonen, Melanoma Cancer Survivor
We are interviewing members of our community about their experience participating in clinical trials. Your story could save lives. If you would like to be interviewed, please complete this quick
Getting treated for cancer during a pandemic SUCKS!
As if the stress of the new life limitations imposed by COVID-19, coupled with the pressure of the economic crisis, weren’t enough, the new way of treating cancer patients really
Cancer can make us voiceless
It doesn’t matter if it is our nature to feel powerful or not. There’s something about this disease that makes us lose our voice and confidence. Even the strongest, most